Intravenous thrombolysis (IVT) appears to be comparatively secure for acute ischemic stroke sufferers who’ve even larger-sized saccular unruptured intracranial aneurysms (UIAs), a Finnish examine suggests.
“I believe there may be now adequate proof that saccular aneurysms shouldn’t be thought of a contraindication for thrombolysis,” Jyri Virta, MD, PhD, with the Department of Neurosurgery and Neurology, University of Helsinki, Finland, informed Medscape Medical News.
However, for stroke sufferers with massive fusiform posterior circulation UIAs, IVT could improve the chance for aneurysm rupture, the information recommend.
“Large fusiform aneurysms can rupture after thrombolysis if the sufferers are handled with anticoagulants as nicely. Overall, sufferers with such unstable aneurysms pose a scientific dilemma and remedy ought to be optimized individually for each such affected person,” Virta mentioned.
Th examine was printed on-line October 6 in Neurology.
Rupture Rare With Saccular Aneurysms
“Great strides have been made to supply IVT to as many acute stroke sufferers as potential. Because of missing knowledge, particularly massive intracranial aneurysms have been thought of a contraindication for thrombolysis. We aimed to make clear this matter,” Virta mentioned.
The researchers decided the frequency of intracranial hemorrhage (ICH) following IVT in 3953 ischemic stroke sufferers handled at a complete stroke middle over 15 years (2005-2019).
A complete of 132 (3.3 %) sufferers had a complete of 155 UIAs (141 saccular and 14 fusiform). The imply diameter of UIAs was 4.7 mm; 18.7% measured ≥7 mm and 9.7% ≥10 mm in diameter.
None of the 141 saccular UIAs ruptured following IVT, “suggesting that thrombolysis is secure in these circumstances,” Virta mentioned.
He famous that IVT has been reported to be administered to acute ischemic stroke sufferers with 300 saccular UIAs (together with sufferers on this examine) and none of them have ruptured.
However, three sufferers (2.3%) with massive fusiform basilar artery UIAs suffered a deadly rupture at 27 hours, 43 hours, and 19 days after thrombolysis. All three have been on anticoagulation following IVT and anticoagulation took impact throughout the UIA rupture.
Among the overall cohort, any ICH and symptomatic ICH have been detected in 18.9% and eight.3% of sufferers, respectively.
Experts Weigh In
Reached for remark, Daniel G. Hackam, MD, PhD, with the Division of Clinical Pharmacology at Western University in London, Canada, mentioned the examine is “fascinating and would recommend, a minimum of for saccular aneurysms, that these usually are not a contraindication to thrombolysis in acute ischemic stroke.”
“The excessive price of ICH in massive fusiform aneurysms would recommend that these are a real contraindication to thrombolysis on this setting. However, it will have been good if the numbers of fusiform aneurysm have been larger. They solely had 14 circumstances of those,” Hackam informed Medscape Medical News.
Also weighing in on the outcomes for Medscape Medical News, Sarah Song, MD, MPH, vascular neurologist at Rush University Medical Center in Chicago, famous that, “Overall, every time somebody has a historical past of an unruptured aneurysm, particularly a big aneurysm, it is a pause, or a consideration, as as to whether thrombolysis will probably be secure to the extent that we quote it’s going to, primarily based upon earlier research.”
Given that IV tissue plasminogen activator (tPA) is the one treatment authorised by the US Food and Drug Administration for acute ischemic stroke, “this will put physicians in a bind when figuring out methods to deal with these sufferers,” mentioned Song, an American Academy of Neurology fellow.
“This examine exhibits that of their pretty massive cohort, the rupture of a saccular aneurysm from IV tPA, even when massive, was unusual, lending credence to the truth that tPA is probably going secure no matter measurement of saccular aneurysm,” Song famous.
“Fusiform posterior aneurysms are totally different in pathophysiology and in outcomes, nevertheless, which the examine does nicely to outline,” she added.
The examine was funded by Helsinki University Hospital. Virta, Hackam and Song have disclosed no related monetary relationships.
Neurology. Published on-line October 6, 2021. Abstract
For extra Medscape Neurology information, be a part of us on Facebook and Twitter